US industry group calls for limited cross-labelling of combination products
This article was originally published in RAJ Devices
Executive Summary
A group of combination product manufacturers has told the US Food and Drug Administration that it should only require cross-labelling in cases where this is necessary for the safety and effectiveness of the products involved1.